Skip to main content
. 2024 Mar 22;16(7):1256. doi: 10.3390/cancers16071256

Table 1.

Bioanalytical characterization of ADCs.

ADC DAR ppm P * ppm S ° mol P/mol S nM N-BPs/mL 2 µg/mL ADC **
Cet-IBA 5.7 65 ± 2 40 ± 4 1.7 74.1
Cet-RIS 7.1 74 ± 2 35 ± 1 2.2 92.3
Cet-ZA 3.6 16 ± 2 38 ± 1 0.4 46.8

DAR: drug–antibody ratio; ° part per million of either phosphorus (*) or sulfur (°). ** Concentration of the N-BPs linked to Cet in the solution used to assess antibody reactivity and functional effects.